JPWO2020181102A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020181102A5 JPWO2020181102A5 JP2021548244A JP2021548244A JPWO2020181102A5 JP WO2020181102 A5 JPWO2020181102 A5 JP WO2020181102A5 JP 2021548244 A JP2021548244 A JP 2021548244A JP 2021548244 A JP2021548244 A JP 2021548244A JP WO2020181102 A5 JPWO2020181102 A5 JP WO2020181102A5
- Authority
- JP
- Japan
- Prior art keywords
- crispr
- activity
- cas effector
- polypeptide
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962815179P | 2019-03-07 | 2019-03-07 | |
| US62/815,179 | 2019-03-07 | ||
| PCT/US2020/021214 WO2020181102A1 (en) | 2019-03-07 | 2020-03-05 | Crispr-cas effector polypeptides and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022522650A JP2022522650A (ja) | 2022-04-20 |
| JPWO2020181102A5 true JPWO2020181102A5 (es) | 2023-03-13 |
Family
ID=72338076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021548244A Pending JP2022522650A (ja) | 2019-03-07 | 2020-03-05 | Ｃｒｉｓｐｒ－ｃａｓエフェクターポリペプチド及びその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210380957A1 (es) |
| EP (1) | EP3935155A4 (es) |
| JP (1) | JP2022522650A (es) |
| CN (1) | CN114040971A (es) |
| WO (1) | WO2020181102A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10660419B2 (en) * | 2016-12-15 | 2020-05-26 | Elc Management Llc | Packaged skin treatment composition and method |
| US10894812B1 (en) | 2020-09-30 | 2021-01-19 | Alpine Roads, Inc. | Recombinant milk proteins |
| US10947552B1 (en) | 2020-09-30 | 2021-03-16 | Alpine Roads, Inc. | Recombinant fusion proteins for producing milk proteins in plants |
| EP4222167A1 (en) | 2020-09-30 | 2023-08-09 | Nobell Foods, Inc. | Recombinant milk proteins and food compositions comprising the same |
| BR112023024985A2 (pt) | 2021-06-01 | 2024-02-20 | Arbor Biotechnologies Inc | Sistemas de edição de genes compreendendo uma crispr nuclease e usos dos mesmos |
| WO2024006824A2 (en) * | 2022-06-28 | 2024-01-04 | Mammoth Biosciences, Inc. | Effector proteins, compositions, systems and methods of use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605709B1 (en) * | 1999-04-09 | 2003-08-12 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics |
| US20040029129A1 (en) * | 2001-10-25 | 2004-02-12 | Liangsu Wang | Identification of essential genes in microorganisms |
| CN1871252A (zh) * | 2003-09-05 | 2006-11-29 | Gtc生物治疗学公司 | 在转基因哺乳动物奶中生产融合蛋白的方法 |
| WO2017117395A1 (en) * | 2015-12-29 | 2017-07-06 | Monsanto Technology Llc | Novel crispr-associated transposases and uses thereof |
| WO2017189308A1 (en) * | 2016-04-19 | 2017-11-02 | The Broad Institute Inc. | Novel crispr enzymes and systems |
| US11692184B2 (en) * | 2017-05-16 | 2023-07-04 | The Regents Of The University Of California | Thermostable RNA-guided endonucleases and methods of use thereof |
| GB201712733D0 (en) * | 2017-08-08 | 2017-09-20 | Snipr Tech Ltd | Methods & cells |
-
2020
- 2020-03-05 JP JP2021548244A patent/JP2022522650A/ja active Pending
- 2020-03-05 WO PCT/US2020/021214 patent/WO2020181102A1/en active Application Filing
- 2020-03-05 EP EP20767083.7A patent/EP3935155A4/en active Pending
- 2020-03-05 CN CN202080030261.1A patent/CN114040971A/zh active Pending
-
2021
- 2021-08-16 US US17/403,236 patent/US20210380957A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019532644A5 (es) | ||
| AU2016316845B2 (en) | Engineered CRISPR-Cas9 nucleases | |
| US10093910B2 (en) | Engineered CRISPR-Cas9 nucleases | |
| JP7210029B2 (ja) | ＣＲＩＳＰＲ－Ｃａｓ９の阻害因子 | |
| US9926546B2 (en) | Engineered CRISPR-Cas9 nucleases | |
| JP6940117B2 (ja) | オンターゲットおよびオフターゲットの多標的システムを用いた標的特異的ヌクレアーゼをスクリーニングするための方法およびその利用 | |
| US10767193B2 (en) | Engineered CAS9 systems for eukaryotic genome modification | |
| JP2023153907A (ja) | Ｒｎａ標的化方法および組成物 | |
| US10822606B2 (en) | Optimized small guide RNAs and methods of use | |
| JP2017018125A5 (es) | ||
| CN116732004A (zh) | CRISPR-Cas效应子多肽和其使用方法 | |
| JP2021121205A5 (es) | ||
| JP2022526695A (ja) | 遺伝子編集における非意図的な変異の阻害 | |
| JP2015503535A5 (es) | ||
| AU2018254616A1 (en) | Inducible, tunable, and multiplex human gene regulation using crispr-Cpf1 | |
| RU2020105703A (ru) | Специфические для мишени варианты, связанные с crispr | |
| AR125191A1 (es) | Enzimas modificadoras del adn y sus fragmentos activos y variantes y métodos de uso | |
| JPWO2020181102A5 (es) | ||
| JP7249620B2 (ja) | 核酸結合因子 | |
| WO2023207607A1 (zh) | 用于修饰线粒体dna的脱氨酶突变体、组合物和方法 | |
| JP6874996B2 (ja) | 人工ｒｎａ制限酵素 | |
| US20240254464A1 (en) | Cleavage-inactive cas12f1, cleavage-inactive cas12f1-based fusion protein, crispr gene-editing system comprising same, and preparation method and use thereof | |
| JPWO2021007563A5 (es) | ||
| WO2022187278A1 (en) | Nucleic acid detection and analysis systems | |
| AR123483A1 (es) | Enzimas modificadoras de adn y fragmentos activos y variantes de las mismas y métodos de uso |